Fc receptors for IgG (FcyR) on macrophages, polymorphonuclear leukocytes, and B and T lymphocytes perform a central role in immune defenses since these receptors link the humoral and cellular effector limbs of the immune system and thus confer an element of humoral specificity on the effector cells that bear FcyR. Recently, two murine FcyR genes, a and #, have been cloned and sequenced (1-3). Transfection of the )3 gene into melanoma cells results in the appearance, on the cell surface, of the epitope recognized by mAb 2AG2, an anti-FcyR mAb (4, 5), and the FcyR binding activity . Both the a and # genes encode proteins containing a leader sequence, NH2-terminal extracellular domains, one putative transmembrane spanning domain, and a cytoplasmic domain. The two genes are 95% homologous in the extracellular domains, which consist of two repeats of 85 amino acids. Moreover, these domains bear significant homology to other members of the Ig gene superfamily, with the most striking similarity found between the #2 domain of mouse ER and the most distal NH2-terminal domain of the FcyR.
mM thymidine, 0.1 mM hypoxanthine, 0.3 mM proline, and 10% FCS (Flow Laboratories Inc., McLean, VA) . Hypoxanthine was omitted and dialyzed FCS was used in medium for selection of transfectants . The 549 .1 cell line was grown in suspension culture in «-MEM (Gibco Laboratories) supplemented with 5% FCS . In some experiments, cells were cultured in serum-free medium, supplemented with a hormone mixture containing transferrin (5 wg/ml), epidermal growth factor (50 ng/ml), bovine insulin (10 Ag/ml), glucagon (1 ng/ml), somatotropin (6.5 ng/ml), and hydrocortisone (3 .5 AM) (7) . Secretory products of transfected and amplified CHO cell lines were biosynthetically labeled with [s5 S]methionine (1,100 Ci/mol ; Amersham Corp., Arlington Heights, IL) in methioninefree medium supplemented with hormones .
Monoclonal Antibodies. The antidinitrophenyl (DNP) mAbs DHK10 .12 (IgG2b) and DH K109.3 (IgGI) were a generous gift of Dr. Schlessinger (Washington University, St. Louis, MO); U12 .5 (IgG2b), U7 .27 (IgG2a), and U7.6 (IgGI) were the kind gift of Dr. Eschar (Weitzmann Institute, Rechovot, Israel) . The myeloma protein MPC-11 (IgG2b) was a gift of Dr. Eisen (Massachusetts Institute of Technology, Cambridge, MA). The anti-DNP mAbs were purified from conditioned medium by affinity chromatography on a TNP 25BSA Sepharose-4B column, and the bound mAb was eluted with 0.1 M DNP, 0.1 M Tris-HCl, pH 8.0. The DNP was removed by gel filtration on Sephadex G-25 .
Plasmid construction . The enzymes used were purchased from New England Biolabs (Beverly, MA) unless otherwise indicated. Calf intestine alkaline phosphatase was from Boehringer Mannheim Biochemicals (Indianapolis, IN) . The methods used for construction of expression vector were based on those of Maniatis et al . (8) . Plasmid 3901, a ,0, cDNA clone (1), was restricted by Apa I at base 947 within the insert and the resulting 3' overhang was blunted by T4 DNA polymerase. The unique Apa I restriction site is 26 by upstream of the transmembrane encoding region and results in deletion of the transmembrane and cytoplasmic domains, leaving a 172-amino acid protein that contains the two extracellular Ig-like domains (see Fig. 1 ). The stop codon was introduced into the reading frame by ligation of the phosphorylated 16-bp universal terminator, GCTTAATTAAT-TAAGC (Pharmacia Fine Chemicals, Piscataway, NJ), to the termini of the linearized plasmid . This results in addition of four accessory amino acid residues, GLIN, before the termination codon is reached . Next, Nco I was used to cut the cDNA at base 338, one base pair before the first methionine codon of the translated sequence. After Hha I digestion to remove concatamerized terminators, the overhangs generated by those two enzymes were blunted by incubation with DNA polymerase Klenow fragment . The 620-bp DNA fragment between Apa I and Nco I restriction sites with the ligated terminator at the 3' end was isolated by preparative agarose gel electrophoresis and ligated into the Sma I restriction site of linearized dephosphorylated pcEXV-3 expression vector (9) . The truncated cDNA insert is predicted to encode a protein with 176 amino acid residues. Two plasmids, pFc-yR, 8-19 ( Fig. 1 ) and pFcyR/3-17, which contain the inserts with sense and antisense orientations, respectively, were obtained after transformation of MM294 .
Transfection of CHO Cell Line and Amplification. The CHO-derived cell line DG44 was seeded at 4 x 105 cells per 100-mm dish and cultured overnight . The cells were cotransfected by incubation with a DNA-calcium phosphate precipitate containing pMG 1 (0.1 Ag per plate), which is the dhfr minigene construct (10), given to us by Dr. Chasin (Columbia University), the FcyR,B cDNA construct (2 Ag per plate), and carrier DNA (20 I.Lg per plate) as described by Wigler et al. (11) . After 2 d, the cells were subcultured and the transfected cells were selected in medium'w ;thout hypoxanthine containing 10% dialyzed FCS . After 2 wk, 0 .02 AM methotrexate was added to the medium followed by stepwise increments every 10 d to 0.05, 0.1, 1 .0, and 2.0 AM methotrexate (12) . The cells were then cloned and clones were screened for secretion of Fc7R,8. The cultures were then maintained routinely in the presence of 2.0 AM methotrexate .
Immunoassays for FcyR,B (ELISA). FcyR,B in cell culture medium or purified FcyRO was titered by a modification of the monoclonal sandwich radioimmune assay described previously (13) . FcyR in assay samples was adsorbed onto flat-bottomed wells (Immulon-2; Dynatech Laboratories Inc., Alexandria, VA) previously coated overnight with rabbit anti-FcyR IgG (5 ug/ml) in PBS and blocked with 3% BSA. FcyR,B was detected by sequential addition of the rat anti-FcyR mAb 2AG2 (5 jig/ml in PBS), biotinylated goat anti-rat IgG antibody (0.5 rig/ml) (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) and streptavidin-horse radish peroxidase (HRP) (0.5 ag/ml) (Kirkegaard & Perry, Inc.), and developed as described (14) . The assay was calibrated by inclusion ofa detergent lysate of S49 .1 cells (1% NP-40 in PBS, 10' cells/ml) .
A similar protocol was used to analyze the binding of the rat anti-FcyR mAbs 2AG2 and 6B7C to flat-bottomed plates coated with OVA or a peptide-OVA conjugate .
Cytoplasmic RNA Dot Hybridization . Preparations of cytoplasmic RNA from tissue culture cells and dot blots were as described by White and Bancroft (15) . Prehybridization and hybridization of blots with probes labeled with a-["P]CTP (3,000 Ci/mmol; Amersham Corp.) by nick translation were carried out as described by Dobner et al. (16) . The probes were the FcyR# cDNA insert of pFcyR#-17 and the rat metallothionein 1 cDNA insert of plasmid p2A10 (17) , kindly donated by Dr. Bancroft (Mount Sinai School of Medicine, New York, NY).
Purification of Truncated FcyR#. Cell culture supernatant containing 5 or 10% FCS was collected and protein precipitated between 40-75% ammonium sulfate saturation was collected by centrifugation . The protein was redissolved in a minimal volume of sodium phosphate buffer (10 mM, pH 7.5) and dialyzed against the same buffer . The truncated FcyR# was isolated by passing the concentrated protein solution over a DHK10 .12 (IgG2bK) Sepharose-4B (Pharmacia Fine Chemicals) affinity column (5-10 mg protein/ml bed volume), which was then washed with sodium phosphate buffer (10 mM, pH 7 .5) containing 50 mM NaCl until the OD2ao returned to baseline . The bound truncated FcyR# was eluted with sodium acetate buffer (0.1 M, pH 4) containing 0.5 M NaCl, and dialyzed versus PBS . The protein at this stage was judged pure by SDS-PAGE.
SDS-PAGE and Immunoblotting. SDS-PAGE was performed using Neville buffers (18) on slab gels. For immunoblotting (19) , nonreduced protein samples were subjected to SDS-PAGE and transferred to nitrocellulose (Bio-Rad Laboratories, Richmond, CA) with a nonbuffer tank electroblotter (Polyblot; American Bionetics, Emeryville, CA) as the manufacturer recommended . After the nonspecific sites were blocked in Tris-buffered saline (TBS) containing 3% BSA, the nitrocellulose was incubated with preimmune rabbit antibodies, rabbit anti-FcyR IgG or rat anti-FcyR mAb 6B7C (20 hg/ml in TBS with 1 BSA) on a miniblotter (Miniblotter II ; Immunetics, Cambridge, MA), followed by biotinylated goat anti-rabbit and goat anti-rat IgG (0 .5 ag/ml each) and streptavidin-conjugated HRP (0.5 Ag/ml). The bound HRP was visualized with 4-chloro-l-napthol (20) .
Assay of Binding of Immune Complexes by Truncated FcyR#. Crystallized BSA was derivatized with DNP groups by reaction with dinitrobenzene sulfonic acid (Pierce Chemical Co., Rockford, IL) in 2% Na2COs, and after gel filtration, the extent of substitution was determined as described previously (21) . The DNP2oBSA (50 tig) was then radiolabeled with 1 mCi ofcarrier-free Na[ 125 1] (Amersham Corp.) using tubes coated with 1 wg of iodogen (Pierce Chemical Co.) (22) . Unincorporated 1251 was removed by gel filtration on a G-25M column . The labeled protein had the sp act of 1 .25 X 10' cpm/wg . Flexible 96-well U-bottomed plates (Micro-2000 ; Dynatech Laboratories, Inc.) were coated with purified truncated FcyR# (5 wg/ml in PBS) at 4°C overnight and the wells were quenched by 3% nonfat dry milk in PBS at room temperature for 2 h. Immune complexes were formed by incubation of serial twofold dilutions of different anti-DNP mAbs with [ 125 1]DNP2oBSA in 0.2X PBS at room temperature for 2 h and the complexes were then transferred to the FcyR#-coated wells. After further incubation a"t room temperature for 2 h, the plates were rapidly rinsed in 10 mM phosphate buffer (pH 7.5) . The wells were cut out and radioactivity was measured by gamma counter (1217 RiaGamma ; LKB-Wallac, Turku, Finland) .
Peptide Synthesis and Conjugation. The peptide ITVQGPKSSRSLPVL, residues 169-183 of FcyR#, was synthesized stepwise by solid-phase methods on an automated peptide synthesizer (model 9500; Biosearch, San Rafael, CA) . A cysteamine residue was attached to the resin through a thioether linkage before start of automated synthesis (23) . After deblocking, this results in a COOH-terminal sulfbydryl group for derivatization . The peptide was purified by reverse-phase chromatography on a Vydac C-18 HPLC column . Amino acid analysis after hydrolysis was consistent with the sequence.
Since the peptide contained a free sulfhydryl group, the bifunctional reagent sulfo-mmaleimidobenzoyl-N-hydroxysuccinimide ester (sulfo-MBS) (Pierce Chemical Co.) was used to make the peptide-protein conjugate, as described by Youle and Neville (24) . Briefly, 5 mg of OVA was dissolved in 0 .5 ml of sodium phosphate buffer (10 mM, pH 7.5) and mixed with 0.5 mg of sulfo-MBS in 10 Al of dimethylformamide by vortexing . The molar ratio of sulfo-MBS to OVA was 8.7:1 . After incubation at room temperature for 30 min, the acylated OVA was desalted over a Sephadex G-25M column (Pharmacia Fine Chemicals) in 10 mM phosphate buffer (pH 7.5) with 15 mM NaCl . The protein was then incubated with 1 mg of peptide in 2 ml of same buffer at room temperature for 2 h. The molar ratio of peptide to OVA was 5.2:1 . The peptide-OVA conjugate, ITVQGPKSSRSLPVL-OVA, was then filtered through a small Sephadex G-25M column .
Disulfide Analysis.
Ellman's reagent (25), 5,5'-dithio-bis(2-nitrobenzoic acid) (Calbiochem-Behring Corp., La Jolla, CA) was used to titrate the number of sulfhydryl groups in the truncated FcyRj6 as described by Anderson and Wetlaufer (26) for peptides . Protein dissolved in 0.1 M acetic acid and 0.2% SDS (0.25 ml) was mixed with an equal volume of 6 N NaOH and boiled for 5 min or incubated at 37°C overnight. The alkaline solution was neutralized by the addition of 0.5 ml of 6 N H3P04 containing 2 mM EDTA. 100 A1 of the Ellman's reagent (1 mg/ml in 20 mM sodium acetate buffer, pH 5.5, with 1 mM EDTA) was then added into the neutralized solution, and the absorbance at 412 nm, due to the release of 2-nitro-5-thiobenzoic acid, was measured. The concentration of free sulfhydryl groups was calculated from the extinction coefficient of 13,600/M/cm (25) . Crystallized BSA was used to determine the yield of free -SH groups per disulfide bond following alkaline cleavage . The yield of -SH/S-S experimentally determined for BSA (1 .31, see Table 11 ) agrees well with the value determined for model peptides (e.g., 1 .34 for oxidized glutathione) (26) .
Deglycosylation.
Digestion of the truncated FcyR# with N-glycosidase F (Genzyme, Boston, MA) was based on the procedure described by Tarentino et al. (27) . Samples were boiled for 3 min in 0.2 M sodium phosphate buffer (pH 8.6) with 10 mM 1,10-phenanthroline hydrate and varying concentrations of SDS, after which they were incubated with N-glycosidase F for 2 h at 37°C.
Results and Discussion
Isolation of the CHO Cell Line Secreting Truncated FcyR#. To convert the FcyR#1, normally an integral membrane protein, to a secreted protein, we deleted the transmembrane and cytoplasmic domains of the receptor, leaving the leader sequence and the extracellular domains . When plasmid 3901, which has a FcyRol cDNA insert encoding signal sequence, extracellular and transmembrane domains, and partial cytoplasmic domain, is cleaved with Apa I the transmembrane and cytoplasmic domains are deleted, leaving a 172-residue protein with two extracellular Ig-like domains (see Fig . I and Materials and Methods) . The truncated FcTR$ protein is also missing eight amino acids just outside the membrane . The truncated FcyR# cDNA was inserted in both orientations into the pcEXV-3 expression vector (9) and transfected along with pCGcos3neo (28) into the B78H 1 melanoma cell line. After G418 selection, transfectants were cloned and supernatants were screened by ELISA. Of 19 clones transfected with pFc7R#-19, 9 secreted immunoreactive material, but none of the 64 clones transfected with pFcyRO-17 were positive . However, the titer of FcyRo in the supernatant of B1904, one of the better secreting lines, based on comparison with lysates of the FcyR+ S49 .1 cell line, was <5 ng/ml (Fig. 2) , which would make further biochemical studies difficult . FIGURE 1 . Construction of the truncated FcyR# cDNA and the expression vector . The plasmid containing the FcyR#1 cDNA insert is illustrated on top left with the predicted coding regions (UT for untranslated region, S for signal sequence, EC for extracellular domains, TM for transmembrane domain, and C for cytoplasmic domain) and the restriction sites for Apa I and Nco 1. Plasmid 3901 is a FcyR,81 cDNA clone that contains the sequence from 5'UT through base 1117 within the C region, as the arrow indicates. The truncated bluntend cDNA was purified from agarose gel and inserted into the Sma I site of pcEXV-3, which is shown on top right. The plasmid pFcyR#-19, which has the sense orientation, is shown on the bottom.
To obtain a higher level of secretion, we transfected pFcyR#-17 and pFc7R#-19 into a DHFR -CHO cell line along with a dhfr minigene, and selected with increasing concentrations of methotrexate . This leads to amplification of the dhfr minigene and flanking transfected FcyR# expression plasmid DNA. The FcyR#-secreting clones were isolated from mass culture after amplification resulting in resistance to 2 jM methotrexate . The level of secretion of truncated FcyR# by the D1959 cell line is elevated over 2,000-fold relative to the B1904 melanoma transfectant (Fig. 2) . As expected, none of the pFcYR,3-17-transfected CHO cells secreted immunoreactive material . Although the slope of the titration of the intact S49.1 cell FcyR is slightly steeper (possibly due to more efficient capture of the intact FcyR by the rabbit anti-FcyR antiserum), we estimate, with a value of 5 X 10 4 FcyR per S49 .1 cell (results not presented), that the concentration of truncated FcyR# in medium conditioned by confluent D1959 cells is 2-3 Ag/ml/d.
The much higher level in synthesis of the truncated FcyR# relative to B1904 and S49 .1 should be paralleled by an increase in mRNA level. Cytoplasmic RNA dot hybridization was performed to investigate the levels of FcyR# mRNA. Hybridization of nick translation-labeled insert of pFcyR#-17 cDNA to cytoplasmic RNA showed a greater than 320-fold higher level of expression of FcyR# message by the D1959 cell line relative to B1904 and 549.1 cell lines (Fig. 3B) . The levels of hybridization to cytoplasmic RNA found with a rat metallothionein cDNA probe were roughly the same for all the cell lines examined (Fig. 3A) .
Identification of the Truncated FcyR#. We examined the total [s5 S]methionine- labeled secretion products from the original CHO DG44 cell line, D1959, and a companion cell line, D1717, which was transfected with pFcyR#-17 and is also resistant to 2 gM methotrexate . No difference in the profile of labeled secreted proteins was detected between the two Fc7R-cell lines DG44 and D1717. However, the profile (Fig . 4) of labeled secreted proteins from D1959 has a major additional peak, centered at M, 31 ,000, which was absent in the DG44 and D1717 cell line labeled secretion products . By densitometry of the autoradiogram we determined that the 31,000 Mr protein comprises 30% of the total secreted proteins . This is probably an underestimate of the actual amount, since there is only one methionine in the sequence of the truncated Fc'YR# (1).
To confirm that the major peak shown in the radiolabeled products is truncated FcyR#, the immunoreactivity of the proteins released from D 1959 was examined by immunoblotting after SDS-PAGE . The rabbit anti-FcyR antibodies specifically bound to the same 31,000 Mr protein (Fig. 5A ) in the secretion products of the D1959 cell line as is seen in the autoradiogram of the [s5S]methionine-labeled secretion products from D1959 cells in Fig. 3 . FcyR from S49.1 cells is considerably larger, with a M,. of 60,000 (5) . The portion that is deleted of the FcyR# is 127 amino acids (for the #1 transcript) or 81 amino acids (for the #2 transcript) and clearly does not account for the difference in Mr seen on SDS-PAGE. The anomalous electrophoretic mobility of the truncated FcyR# may be due to carbohydrate . Characterization of the Truncated FcyR#. The truncated FcyR# was purified to homogeneity from the medium conditioned by the D1959 cell line by one cycle of affinity chromatography on IgG2b-Sepharose 4B (Fig. 6 , Table I ). The first step was a 40-75% saturated ammonium sulfate precipitation of conditioned medium followed by dialysis . This step functions both to concentrate the FcyR# and to lower the ionic strength, which leads to tighter binding of the FcyR# to the IgG matrix . The affinity column removed >99% of immunoreactive material from the initial concentrated conditioned medium. Recovery of truncated FcyR# frbm the concentrated conditioned medium was >85% . The purified protein shows the same broad electrophoretic mobility on SDS-PAGE (Fig. 7, lane C) and has the same activity with rabbit anti-FcyR antibodies in immunoblotting ( Fig. 5B) as the immunoreactive material in the conditioned medium . Based on amino acid composition with four tryptophan and eight tyrosine residues, the truncated FcyRo should have an E280 = 33,000 M-' cm-' (30) . Given an M, of 31,000 for the truncated FcyR#, the yield of purified protein by measuring OD280 is 2.5 Ag/ml conditioned medium, in good agreement with the ELISA assay titration.
The external domain of the FcyR has four cysteine residues, two located in each Ig domain (1, 2) . We performed titrations using Ellman's reagent, 5,5'-dithio-bis-(2-nitrobenzoic acid) to determine the number of free cysteine residues and found that truncated FcyR,Q has no free sulfhydryl groups (Table II) . Alkaline hydrolysis of BSA resulted in 22 .9 free -SH groups per mol, a ratio of 1 .3 titratable -SH per disulfide bond . This value is in agreement with literature reports (26) for the yield of free sulfhydryls from model disulfide-containing Purification of the Truncated FcyR#from Cell Culture * Titer is expressed as the reciprocal of the dilution . $ Proteins were quantitated by Lowry's method (29) . 4 Comparison of the activity recovered from IgG2b affinity column . The titer of cell culture supernatant is the average value of several separate assays and was determined, in any one set of assays, by the titer resulting in 50% maximum OD4yo. The total activity of the concentrated supernatant was always somewhat higher (50-100%) than that of the starting cell culture supernatant. (31) .
Since titration with Ellman's reagentof albumin without hydroxide cleavage was negative, we assume the albumin preparation was dimerized. 4 Calculated from this experiment by dividing experimental -SH/S-S for albumin into the -SH/protein obtained for the truncated FcyR#. Step of purification Volume the presence of intrachain disulfide bonds (data not shown) . Like many other members of the Ig gene superfamily, the cysteines form intramolecular linkages in the FcyR# and, therefore, the two repeats of the extracellular domain form two loops, although these loops are much shorter (42-45 amino acids) than in other members of the family . The predicted amino acid sequence of moFcyR (both a and # genes) has four potential sites for N-linked glycosylation (1, 2). Limited endoglycosidase F digestion of FcyR isolated from J774 after a short pulse with [s5S]methionine resulted in five intermediates, consistent with four glycosylation sites (32) . The truncated FcyR# purified by affinity chromatography on IgG2b-Sepharose 4B shows the same broad electrophoretic mobility as the intact FcyR, suggesting it is also glycosylated . Digestion of the truncated FcyR# with N-glycosidase F confirmed the presence of carbohydrate (Fig. 7) , and resulted in a deglycosylated core of 19,000 M,., which is in agreement with the predicted length of the peptide backbone of the truncated FcyR#, 176 amino acids. The protein could be deglycosylated only after partial denaturation, either by SDS or by boiling; intact truncated FcyR was very poorly digested by N-glycosidase F. The 12,000 M, difference between the glycosylated and deglycosylated truncated FcyR# is somewhat less than that found for J774 Fc7R (60,000 versus 37,000 M,).
The Biological Activity of the Truncated FcyR#. The purification of truncated FcyR# by affinity chromatography on IgG2b-Sepharose demonstrated the retention of specificity of the recombinant truncated receptor . To determine the isotype specificity of the truncated Fc7R#, we examined the binding of ['25I]-DNP2oBSA-anti-DNP mAb complexes to truncated FcyR# adsorbed to microtiter plates . Labeled immune complexes formed from IgGI anti-DNP mAbs (U7.6 and DHK 109.3), IgG2a (U7.6), and IgG2b (DHK10 .12) bound to the truncated FcyR# (Fig. 8) . The avidity of the truncated FcyR# for IgG 1 antibodyantigen complexes was significantly stronger than that for IgG2a and IgG2b complexes. However, no binding was observed for the IgG2b anti-DNP-mAb U 12.5, which may be due to a low avidity of U 12 .5 for DNP. No binding was seen for the MPC-11 control (Fig. 8D) . From these results, we conclude that the affinity of the truncated FcyR# for murine IgG isotypes as immune complexes is IgGl>IgG2b=IgG2a .
Using the same assay for binding of immune complexes, we examined the effect of pH on truncated FcyR# activity using the IgGl anti-DNP mAb U7 .6. There was more binding of the labeled DNP2oBSA in immune complexes at more acid pH (Fig. 9) . This differs from a previous report by Mellman and Unkeless (5) Binding by truncated FcyRo of IgGI U7 .6 immune complexes as a function of pH . Citrate-phosphate buffer was used for pH 3-5, sodium phosphate buffer for pH 6-8, and glycine buffer for pH 9-10 (33) . All buffers were adjusted to 10 mM and contained 0.1 M NaCl . The immune complex was prepared as described in Fig. 8 with a final concentration of 5 fag/ml U7 .6 and 0.5 ug/ml phages, to rabbit immune complexes was examined, and found to decrease sharply at pH 5 .0. The failure of FcyR internalized with immune complexes to recycle to the cell surface, but rather to be digested in the lysosomal compartment (34, 35) , is more easily explained by the failure of the receptor-ligand complex to dissociate at acid pH. The intact FcyR in the absence of detergent exists in a protein micelle, due to aggregation of the hydrophobic transmembrane domains. It is possible that this micelle at low pH dissociates, resulting in a loss of cooperative binding necessary for binding to the immune complexes. This consideration did not apply in the present experiments in which the truncated FcyR# was adsorbed onto the plastic surface .
Mapping ofthe Epitope Recognized by mAb 6B7C . 6B7C is an anti-moFcyR mAb that effectively reacts with FcyR from all cells after SDS-PAGE and transfer to nitrocellulose . However, it reacts variably with FcyR on viable FcyR + cells. For example, mAb 6B7C binds to the surface of LPS-activated B cells and J774 cells, but not to primary macrophages or B cells (36) . When we attempted to detect the secreted FcyR# using mAb 6B7C, we were surprised to find that this antibody did not recognize the truncated FcyR# on immunoblots (Fig. 5) . Furthermore, although in the ELISA assay, mAb 6B7C bound to the FcyR# from detergent lysates of S49.1 cells as well as mAb 2AG2 did, it failed to react with the truncated FcyR# (Fig. 10 A) .
Since the truncated FcyR# is missing the 8 amino acids nearest the membrane of the external domain, the epitope may be in the deleted peptide. Alternatively, it is also possible that the FcyR# made in CHO cells is different by virtue of altered glycosylation, or that the truncated FcyR#, due to altered conformation, has lost the 6B7C epitope. To test these possibilities, we synthesized the peptide ITVQGPKSSRSLPVL (amino acids 169-183 of the FcyR#) and tested this peptide, coupled to OVA, as a ligand . As can be seen in Fig. 10B , 6B7C bound to ITVQGPKSSRSLPVL-OVA-coated wells in a dose-dependent fashion, but there was no binding of either 6B7C to OVA-coated wells, or 2AG2 to either OVA-or ITVQGPKSSRSLPVL-OVA-coated wells. These results indicate that the epitope recognized by mAb 6B7C is certainly within amino acids 169-183 and that crucial residues for the 6B7C epitope lie after residue 173 (the terminus of the truncated FcyR#) . Furthermore, since the predicted FcyRa and FcyR# protein sequences are quite different in this region, mAb 6B7C is a FcyR#-specific probe, which we have confirmed in preliminary experiments (Schreiber, R., and J. Unkeless, unpublished results) . The location of the 6B7C epitope, just at the plasma membrane, suggests that the epitope may be masked, perhaps by other proteins or cell surface constituents, in the cells bearing FcyR,Q that fail to bind mAb 6B7C .
We have isolated a recombinant secreted FcyR# molecule by deletion of the transmembrane and cytoplasmic domains encoding sequence from a FcyR#1 cDNA clone, and insertion of the truncated cDNA into a eukaryotic expression vector, pcEXV-3 . To express and amplify the production ofthe truncated Fc'YR# molecule, we transfected the truncated cDNA plasmid into a dihydrofolate reductase-minus CHO cell line along with a dhfr minigene, and amplified the gene products with methotrexate. The resulting cell line secretes 2-3'Ug/ml/24 h of truncated FcyR#, which can be readily purified by affinity chromatography on IgG-Sepharose . The truncated FcyR# has a Mr of 31-33,000 on SDS-PAGE and is glycosylated. N-glycosidase F cleavage reduces the Mr to 19,000, consistent with the size of the truncated product, 176 amino acid residues. There are two disulfide bonds in the protein . Binding of immune complexes formed between DNP20BSA and anti-DNP mAbs reveals better binding of IgGI aggregates than that of IgG2b and IgG2a aggregates . The binding of the immune complexes was somewhat better at more acidic pH, in contrast to previous experiments with binding of purified FcyR to immune complex-coated beads.
We were surprised to observe that the truncated FcyR# did not react with the anti-FcyR mAb 6B7C. Previous work had shown that 6B7C reacts with Fc-YR on immunoblots, fails to bind to the surface of resting B cells and peritoneal macrophages, but does bind to macrophage cell lines and LPS-stimulated B cells. We show, by binding of mAb 6B7C to a peptide conjugate, that the 6B7C epitope lies within residues 169-183 of the intact FcyR#, which is just outside the plasma membrane.
